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a b s t r a c t
There is emerging evidence that asthma and atopy may be associated with a higher risk of suicide. We
investigated the association of asthma and atopy with mortality from suicide (n¼32) in the Glasgow
Alumni cohort, adjusting for the key confounders of socioeconomic position and smoking. We found no
evidence of an association in our a priori atopy phenotypes with suicide, and there were insufﬁcient
suicides in the asthma phenotypes to draw any conclusions. In additional analyses, individuals reporting
both eczema–urticaria and hay fever and those with family history of atopy were at higher risk of
suicide. As these were secondary analyses and based on small numbers of events we cannot rule out
chance ﬁndings. The lack of evidence in our main hypothesis may be due to the small number of suicides
or reported associations between asthma and atopy may be confounded.
& 2014 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY
license (http://creativecommons.org/licenses/by/4.0/).
1. Introduction
In 1966 Paffenbarger reported a higher percentage of allergic
reaction to irritants and a consistent, “although not statistically
signiﬁcant”, higher percentage of asthma, among students who
had died by suicide compared to controls (Paffenbarger and Asnes,
1966). Since then, a systematic review (Iessa et al., 2011) and
additional papers (Timonen et al., 2001; Kuo et al., 2010; Qin
et al., 2011; Loerbroks et al., 2012) have documented a higher risk
of suicide ideation, attempt or death as well as depression among
asthmatics and/or people with reported or measured atopy.
Despite this increasing evidence, important confounders such as
socioeconomic position (SEP), smoking and comorbidities were
not available in all studies and so may have confounded these
reported associations (Woo et al., 2012). Few studies include actual
deaths by suicide (Paffenbarger and Asnes, 1966; Kuo et al., 2010;
Qin et al., 2011), some with a very small number of deaths
(Goodwin and Eaton, 2005). Other studies have amalgamated
different asthma/atopy phenotypes making it difﬁcult to investi-
gate whether there is a common aetiological pathway between
asthma/atopy and suicide. The Glasgow Alumni study is a histor-
ical cohort of university students, with relatively homogenous SEP
in adulthood, and information available on smoking in early
adulthood (McCarron et al., 1999). In addition, a subsample of
the cohort provided data on depression and mental health. The
aim of this study was to investigate the association of pre-deﬁned
asthma and atopy phenotypes reported in young adulthood with
later suicide.
2. Methods
Students who attended the University of Glasgow between 1948 and 1968 were
invited to an annual medical examination at the Student Health Service with
approximately 50% of the students attending (n¼15,322, 77% male, mean age 20.9
years (S.D. 4.0)) (McCarron et al., 1999). Sociodemographic and medical data were
collected through a physician administered questionnaire and physical examina-
tion. Students reported “Past Medical History” of, among other conditions, having
ever had i) asthma, ii) eczema–urticaria, and iii) hay fever. Eczema and urticaria
were asked jointly in the questionnaire and could not be separated in the analysis.
The following asthma and atopy phenotypes were initially investigated: asthma
(regardless of atopic status), atopy (eczema–urticaria and/or hay fever, regardless of
asthma status), and phenotypes based on the combination of these two conditions:
asthma with atopy (asthma and eczema–urticaria or hay fever), asthma without
atopy (asthma without eczema–urticaria or hay fever) and atopy alone (eczema–
urticaria or hay fever without asthma). Secondary analyses investigated all
combinations of the two atopic conditions, eczema–urticaria and hay fever, as
well as family history of these conditions.
Between 2001 and 2002, members of the cohort who were still alive (n¼8410)
were contacted through a postal questionnaire and 5569 (66%) responded to this
follow-up. The General Health Questionnaire (GHQ-12) (Goldberg, 1978) and
history of depression in adulthood were collected in this subsample; a score of
four or more on the GHQ-12 was used to indicate poor mental health. We
investigated the association of asthma and atopy reported at baseline with the
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GHQ-12 and history of depression in adulthood in the sub-sample of questionnaire
respondents. The National Health Service Central Register (NHSCR) carried out
tracing of the students and provided notiﬁcation of the date and cause of death,
area of current residence, and emigration details. Deaths up until the end of 2012
were included. ICD-9 and ICD-10 codes were used to classify suicides into
intentional self harm (ICD9: E950–E959; ICD10: X60–X84) and deaths of unde-
termined intent (ICD9: E980–E989, excluding E988.8; ICD10: Y10–Y34). Deaths of
undetermined cause were also included in our analyses as most such deaths were
suicides (Linsley et al., 2001).
Cox proportional hazards regression models were used to investigate the
association of asthma and atopy with suicide using age as the time axis. The
assumption of proportional hazards across exposure groups was formally tested
with the Schoenfeld test. All models were adjusted for year of student examination
to control for potential confounding from the change over time of disease
prevalence or deﬁnitions. The ﬁnal model contained terms for year of student
examination, sex, height, number of siblings, birth order, father's social class
measured with occupational class using the Registrar's Social class classiﬁcation,
body mass index (BMI) and smoking. In addition we investigated the association
between poor mental health (GHQ-12 score of 4 or more) and suicide in the
subsample.
3. Results
Students who could not be traced or who had missing exposure
data were excluded from this analysis, yielding a total sample of
11,463 (8938 male, 78%) individuals among whom there were 32
suicides (29 male) up to the end of 2012. The incidence of suicide
in this study was 5.52 per 100,000/year, which was substantially
lower than the UK average (11.8 per 100,000/year) (ONS, 2013).
The prevalence of asthma was higher in males than females (3.7%
vs. 2.3%, p¼0.001), while the prevalence of atopy was higher in
females than males (12.3% vs. 9.2%, po0.001). The median age of
study members at the time of university medical examinations
was 19.4 years (range 16–53). We found no evidence of an
association of asthma and/or atopy phenotypes in young adult-
hood with later suicide in our a priori groups (Table 1). However,
in additional analysis of secondary outcomes, individuals with a
combination of eczema–urticaria and hay fever, and a family
history of atopy were associated with higher risk of suicide
(Table 2).
Students with missing data in the postal questionnaire were
excluded, yielding a total subsample of 4746 (3568 male, 75%; 85%
of the 5569 students who responded) individuals among whom
there were ﬁve suicides (5 male) up to the end of 2012. A greater
proportion of females reported a diagnosis of depression (19.5% vs.
14.9%, po0.001), or reported poor mental health (GHQZ4) (14.3%
vs. 10.0%, po0.001) compared to males. There was no evidence of
an association between asthma (OR 1.10, 95%CI 0.66, 1.85, p¼0.71),
atopy (OR 0.89, 95%CI 0.66, 1.22, p¼0.47), eczema–urticaria and
hay fever (OR 0.31, 95%CI 0.04, 2.34, p¼0.26), family history of
atopy (OR 1.12, 95%CI 0.79, 1.59. p¼0.52), or any other phenotype
with a GHQ-12 score of 4 or more, or with history of depression
measured in adulthood (p40.05). There was weak evidence that
poor mental health (GHQ-12 score of 4 or more) was associated
with higher risk of suicide (model 2 adjusted HR 6.14, 95%
conﬁdence interval (CI) 0.95, 39.56, p¼0.056).
4. Discussion
Contrary to previous studies (Kuo et al., 2010; Iessa et al., 2011;
Qin et al., 2011) we found no evidence for our a priori hypothesis
of an association of asthma and/or atopy phenotypes in young
adulthood with later suicide. However, individuals with a family
history of atopy or both eczema–urticaria and hay fever were
associated with a higher risk of suicide. As these were secondary
analyses and based on small numbers of events we cannot rule out
chance ﬁndings.
The selective, relatively well-off population in our study (for-
mer university students) meant that residual confounding by SEP
in adulthood is unlikely. However, their afﬂuence may have
contributed to the low incidence of suicide in this sample and so
limited the power to detect clinically important associations with
our a priori phenotypes. On the other hand, this is one of the only
a few studies to investigate the association between asthma or
atopy with death from suicide, as opposed to suicidal ideation or
attempted suicide (Paffenbarger and Asnes, 1966; Goodwin and
Eaton, 2005; Kuo et al., 2010; Qin et al., 2011, 2013), an approach
recommended in a recent review on this topic (Goodwin, 2012).
A small number of suicides in this study limited the power to
detect associations increasing our chance of reporting type II
errors. In one of our a priori hypotheses there were 5 suicides
from 1132 individuals reporting atopy compared with 27 suicides
from 10331 individuals not reporting atopy. A retrospective power
calculation performed using stata (StataCorp, 2013) calculated we
had 25% power at 5% signiﬁcance level to detect an HR of 1.69 or
more. To achieve 80% power at a 5% signiﬁcance level it would
require a total sample size of approximately 34,000 individuals,
with equal numbers in the atopy and no atopy groups. Alterna-
tively, given our sample size and the number of suicides in
individuals with no atopy, at 80% power and a 5% signiﬁcance
level we were only able to detect an effect size approximately
twice the size of that observed (an HR3.23 compared with an
HR1.69 observed for atopy analysis). Previous studies have
reported that asthma or atopy is associated between a 1.2 and
3.5 times higher odds of suicidal ideation, suicide attempts or
completed suicide (Goodwin and Eaton, 2005; Messias et al., 2010;
Qin et al., 2011).
A potential source of bias could be due to only half of the
students who were invited to the medical examination actually
attending. If those who did not attend the medical examination
had a higher prevalence of asthma/atopy, and there were more
suicides in this group of individuals, then the results of this study
would be biased towards the null. This limitation is also relevant to
Table 1
Hazard Ratio (HR) and 95% Conﬁdence Interval (CI) of a priori exposures with death from suicide.
Exposure Individuals (%) Suicides (n) Model 1 HR (95% CI) Model 2 HR (95% CI)
Asthma (with or without atopy)a 387 (3.4) 1 0.92 (0.13–6.76) 0.92 (0.13–6.73)
Atopy (with or without asthma)a 1132 (9.9) 5 1.68 (0.65 –4.36) 1.69 (0.65–4.40)
Asthma and atopy phenotypes
No asthma, no atopy (reference group) 10089 (88.0) 27 1.00 1.00
Asthma with atopy 145 (1.3) 1 2.50 (0.34–18.40) 2.55 (0.35–18.89)
Asthma without atopy 242 (2.1) 0 – –
Atopy without asthma 987 (8.6) 4 1.51 (0.53–4.32) 1.51 (0.53–4.34)
Model 1 adjusted for year of examination. Model 2 also adjusted for sex, height, number of siblings, birth order, fathers social class, body mass index and current smoking.
a There were a total of 32 suicides in the cohort of 11,463.
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the postal questionnaire where individuals with more severe
asthma, atopy or depression may be less likely to respond. This
may explain why we failed to ﬁnd evidence of an association as
strong as has been previously reported and thus a lack of evidence
supporting our a priori hypotheses.
We report an association between family history of atopy with
a higher risk of suicide which supports previous work reporting an
association between family history of atopy and depression
(Timonen et al., 2003). Twin studies have suggested a shared
genetic risk for atopic and depressive symptoms (Wamboldt et al.,
2000). However, a shared genetic risk would not fully explain our
results as it appears a family history of atopy is a stronger risk
factor than having atopy yourself. It may be that atopy conveys
risk, but its treatment, in particular with intranasal or inhaled
corticosteroids reduces the risk (Woo et al., 2011). In addition,
exposure to molecular mediators of atopy, or atopy medication
during pregnancy may inﬂuence brain development and increase
the risk of suicide in the offspring. A limitation of this study is that
medication data or data on other physical diseases were not
included in the analyses but may be confounding the results.
There was only 1 suicide in the asthma group which limited the
conclusions that could be drawn.
Our ﬁnding that individuals with both eczema–urticaria and
hay fever are at a 9 fold higher risk of suicide is consistent with
other reports of only severe atopy being associated with suicide in
a Danish record-linkage study (Qin et al., 2011) and a dose-
response association between air pollen counts and suicide (Qin
et al., 2013). This type of dose-response association has also been
reported between the severity of asthmatic symptoms and sub-
sequent suicide risk (Kuo et al., 2010). However, in our analysis, the
ﬁnding was based on only two suicides and there was no
association with other measures of mental health, so must be
interpreted with extreme caution.
Several mechanisms could explain an association between
asthma and/or atopy with suicide: i) confounding due to cigarette
smoking, child and/or adulthood deprivation and other demo-
graphic characteristics. We could account for some of these in our
analysis and through the study design. In addition, depression or
other mental health comorbidities may be confounders if they are
not on the casual pathway; ii) hopelessness experienced due to
suffering a lifelong chronic condition (Goodwin and Buka, 2008);
and, iii) a common risk factor, related to inﬂammatory processes,
to which both conditions are related (Miller et al., 2009). Our
results point to processes related speciﬁcally to atopic conditions.
As noted above an association with family history of atopy could
suggest shared genetic or biological traits.
This study adds to the growing body of research investigating
the association among asthma, atopy and suicide. Our study
included deaths from suicide rather than ideation and could
account for some relevant confounders. Replication of these
ﬁndings in other populations with comprehensive information
on confounders, particularly life course mental history, and biolo-
gical markers of potential aetiological mechanisms is necessary.
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